These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3766081)

  • 1. Preparation of anhydro-thrombin and its interaction with plasma antithrombin III.
    Tomono T; Sawada E
    Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):969-79. PubMed ID: 3766081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Separation and purification of antithrombin III, thrombin and carboxypeptidase N using affinity sorption on the copolymer hydroxyalkylmethacrylate with immobilized heparin (heparinoid)].
    Rybák M; Coupek J
    Cesk Farm; 1982 Jan; 31(1):27-9. PubMed ID: 6176339
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombin III inhibition of the reaction to thrombin excitation of the anticoagulation system].
    Strukova SM; Umarova BA; Golubeva MG; Dugina TN; Bashkov GV
    Biull Eksp Biol Med; 1987 Mar; 103(3):268-70. PubMed ID: 3828498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
    Funahashi M; Matsumoto I; Seno N
    Anal Biochem; 1982 Nov; 126(2):414-21. PubMed ID: 7158775
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological action and clinical significance of antithrombin III.
    Abildgaard U
    Haematologia (Budap); 1984; 17(1):77-9. PubMed ID: 6724354
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on antithrombin III. I. Purification and some properties of antithrombin III (ATIII), and the relationship between plasma antithrombin activity and ATIII antigen concentration (author's transl)].
    Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):879-88. PubMed ID: 7234301
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
    Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
    Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of the thrombin/antithrombin III reaction from amidolytic activity of the enzyme at high salt concentration.
    Oshima G
    Thromb Res; 1989 May; 54(3):225-35. PubMed ID: 2749614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of in vivo and in vitro inhibition of thrombin by plasma inhibitors.
    Vogel CN; Kingdon HS; Lundblad RL
    J Lab Clin Med; 1979 Apr; 93(4):661-73. PubMed ID: 429864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III].
    Boyer-Neumann C; Wolf M; Larrieu MJ
    Ann Biol Clin (Paris); 1987; 45(2):175-80. PubMed ID: 3619143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A kinetic micromethod of determining the activity of antithrombin III].
    Ivanov EP; Biziuk LA
    Lab Delo; 1989; (11):56-9. PubMed ID: 2481106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin.
    Machovich R; Blaskó G; Borsodi A
    Thromb Haemost; 1976 Dec; 36(3):503-8. PubMed ID: 65798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation of specific sorbents with polyclonal antibodies as a ligand for purification of human antithrombin III.
    Rogalski J; Dawidowicz AL; Wiater A; Gibuła K; Winiarczyk S
    Acta Microbiol Pol; 1998; 47(2):153-65. PubMed ID: 9839374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system".
    Rosenberg RD; Bauer KA; Marcum JA
    J Med; 1985; 16(1-3):351-416. PubMed ID: 3915998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.